What's breaking now, across thousands of outlets.
Fresenius Kabi will sell biosimilars directly to employers. To accomplish that, the drugmaker is working with Eversana-owned Waltz Health, which runs a marketplace that helps employers shop for better deals on prescription ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
During Donald Trump’s first presidency, American public opinion broadly shifted leftward. But a new study reveals this "liberal rebound" was accompanied by surging emotional hostility between…
Drugmakers and investors have ramped up their spending and R&D attention on autoimmune diseases in recent years, with a proliferation of bispecific T cell engagers, various approaches to CAR-T cell…
Deadly synthetic opioids disguised as legitimate painkillers are being sold online across Europe, as counterfeit medicines linked to multiple deaths in the Netherlands expose the dark side of…
Infections caused by viruses, bacterium and parasites caused an estimated 2.3 million new cancer cases in 2024, with low- and middle-income countries bearing most of the burden.
After last year's successful $10 billion sale of Metsera, then launching an inflammatory disease biotech earlier this year, ARCH Venture Partners and Population Health Partners have teamed up again…
President Donald Trump regularly defends his administration's record by contrasting it favorably with the Biden era, or other blaming the former president.
